Jacqueline Saw retweeted
Premenopausal women with ACS are often labeled “low risk.” The reality: rising MI rates, more delays and misdiagnoses, and worse outcomes vs men.
ACS in younger women is different and needs tailored care, earlier recognition, and equity in treatment.
ahajournals.org/doi/10.1161/…
ALT Screening • Use validated instruments to screen for depression and anxiety (eg, BDI-II, PHQ-9, GDS, HADS) • Optimal timing of screening is uncertain but could be conducted at intervals post-ACS • Consider referral to mental health care professional Diagnosis • Confirm diagnosis of depression or anxiety, or both, prior to initiating treatment Treatment • Use shared decision-making to inform treatment decision • CBT and antidepressant mediations (eg, SSRI) are options and may be used together for optimal effect Re-Assessment • Reassess depression or anxiety, or both, symptoms and necessity of continued treatment or modification to treatment plan
Jacqueline Saw retweeted
Privileged to take part in an outstanding #ACC26 session on #LAAO. A rigorous, balanced and forward-looking discussion of the latest evidence and the promise of next-generation devices. @ACCinTouch @DeeDeeWangMD @cellisvandyep @MarieF_Poulin @docsaw
@AGoldsweig
Jacqueline Saw retweeted
Congratulations Mme President @Drroxmehran
🎉🎊 💃
Looking forward to a year of many successes & growth under your leadership @ACCinTouch
We're thrilled to celebrate #TCT2026 Program Director, Dr. Roxana Mehran as she officially assumes the role of President of the American College of Cardiology at #ACC26! ✨
A visionary and trailblazer in #interventionalcardiology, Dr. Mehran's leadership and dedication to advancing cardiovascular care continue to inspire the global community. 🌎🫀
We couldn't be prouder of this well-deserved achievement and look forward to the extraordinary impact she will make in her new role.
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @ColletCarlos @georgedangas @jgranadacrf @mbmcentegart @Drroxmehran @sahilparikhmd @PopmaJeffrey @triciarawh @mirvatalasnag @TCTConference @TCTMD
Jacqueline Saw retweeted
🔓 For a limited time until January 31, we are offering free promotional access to this new article in #CJC! 🌐
Intravenous thrombolysis in SCAD: insights from the Canadian SCAD Study ⬇️
onlinecjc.ca/article/S0828-2…
@vanscad @docsaw @CardioUBC
Jacqueline Saw retweeted
To date there has been no attempt to develop integrated management pathways for the diagnosis and management of premenopausal women presenting with ACS.
This statement discusses key considerations for invasive angiography, revascularization, and related procedures such as arterial access, intravascular imaging, left ventricular angiography, invasive physiology, and provocative testing.
✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag
📷 Diagnosis and management of ACS in premenopausal women.
Jacqueline Saw retweeted
Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and are and often under-recognized patient population; this paper discusses the unique numerous challenges associated with their care.
✍🏼 @docsaw @EstherSHKimMD @JohnBlakeman_RN @hollandtamis @MonSangh @MirvatAlasnag
Jacqueline Saw retweeted
2/ View the paper and supplemental resources here: spr.ly/6011hGFif
Jacqueline Saw retweeted
Register here: csi-congress.org/conferences…
Explore the program: csi-congress.org/conferences…
Jacqueline Saw retweeted
Make sure you don't miss #CSILAA2025, a leading conference on stroke prevention atrial fibrillation!
What makes CSI Focus LAA special?
Well, there are a couple of reasons:
🎤 The interactive sessions allow you to have your opinions heard and questions answered
☕ Learn and have a discussion about intriguing and challenging real-world cases in the informal, yet proven format of our popular Cathlab café
🫀 Receive valuable hands-on experience in our new CSI 360° training
📹Live cases from renowned centers give you the opportunity to learn from the best operators
🤝 Participate in discussions and network with faculty and colleagues from all over the world.
And last but not least, CSI Focus LAA will be held in conjunction with CSI Focus D-HF, the leading conference in the field of device-based heart failure therapy.
Feel the synergy at the joint session: heart failure and AF!
Jacqueline Saw retweeted
Two leading cardiology meetings, one venue 💓🫀
Register for CSI Focus D-HF or CSI Focus LAA — and benefit from both conferences happening side by side in Frankfurt, Dec 5-6 2025!
Special highlight: Joint session: heart failure and AF
Jacqueline Saw retweeted
Last month's #VanSCAD conf was 3-days worth of interdisciplinary knowledge exchange. TY to clinicians, nurses, research teams & industry partners. The future for #SCAD & #NOCAD is bright 🌟 @drdavidawood @docsaw #womenshearthealth #herheartmatters Link: bit.ly/4nPNeTB
Jacqueline Saw retweeted
Check out the new SCAD Navigator website made by the Vancouver SCAD team. @docsaw
scadnavigator.com
Jacqueline Saw retweeted
Such a great document! Congratulations to the entire amazing team @SuzanneJBaron @docsaw @mirvatalasnag @AlexandraLansky et al! 👏🏽👏🏽👏🏽
Jacqueline Saw retweeted
Excited to share our group's key takeaways from the Academic Research Consortium on LAAC. Join us Wednesday at 945 am! #EuroPCR @Drroxmehran @DrGarot Horst Sievert @docsaw @CERC_CRO Marie-Claude Morice Davide Capadanno
CERC at #EuroPCR 2025
We’re delighted to be part of EuroPCR 2025, taking place at the Palais des Congrès in Paris!
🌟Join us at Booth M11 (Level 2) for an exciting experience!
🗓️Dive into our cutting-edge innovations and the next-level research
@PCRonline
Jacqueline Saw retweeted
@docsaw is the global expert on this, and just by chance her excellent annual meeting (#VanSCAD) starts tomorrow
vanscad.ca/
It's aimed across the board from patients to healthcare experts
Jackie - is there anything known how to reduce SCAD risk?
